Prostate Cancer

Prostate cancer in mice blocked by new antiangiogenic agent and radiation

Published in Cancer Weekly, November 1st, 2005

Researchers at Montefiore Medical Center have discovered that a combination of gene therapy and radiation inhibits the growth of prostate and lung cancer tumors in mice increasing their lifespan, it was reported recently at the American Society of Therapeutic Radiation and Oncology (ASTRO) meeting in Denver, Colorado.

The gene therapy involves a new protein, called Tek-Fc, which blocks angiogenesis, or the growth of blood vessels that are crucial for the continued growth of tumors.

"This anti-angiogenic gene therapy could eventually be an effective adjuvant to radiation therapy in the treatment of prostate and lung cancer in humans," said Madhur...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2005-11-01)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry